Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 317,716 shares of BLFS, which is worth approximately $7.43 Million. The most recent transaction as insider was on Aug 23, 2021, when has been sold 10,000 shares (Common Stock) at a price of $46.54 per share, resulting in proceeds of $465,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 318K

0.14% 3M change

15.56% 12M change

Total Value Held $7.43 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 23 2021	SELL Open market or private sale	$465,400 $46.54 p/Share	10,000 Reduced 4.55%	209,589 Common Stock
Aug 23 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.36%	219,589 Common Stock
Jul 21 2021	SELL Open market or private sale	$403,831 $45.61 p/Share	8,854 Reduced 4.05%	209,589 Common Stock
Jul 21 2021	BUY Exercise of conversion of derivative security	$14,521 $1.64 p/Share	8,854 Added 3.9%	218,443 Common Stock
Jul 19 2021	SELL Open market or private sale	$438,500 $43.85 p/Share	10,000 Reduced 4.55%	209,589 Common Stock
Jul 19 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.36%	219,589 Common Stock
Jun 29 2021	SELL Open market or private sale	$31,281 $43.75 p/Share	715 Reduced 0.34%	209,589 Common Stock
Jun 16 2021	SELL Open market or private sale	$392,700 $39.27 p/Share	10,000 Reduced 4.54%	210,304 Common Stock
Jun 16 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,304 Common Stock
Jun 14 2021	SELL Open market or private sale	$389,000 $38.9 p/Share	10,000 Reduced 4.54%	210,304 Common Stock
Jun 14 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,304 Common Stock
May 28 2021	SELL Open market or private sale	$12,701 $33.87 p/Share	375 Reduced 0.18%	210,304 Common Stock
May 19 2021	SELL Open market or private sale	$314,500 $31.45 p/Share	10,000 Reduced 4.53%	210,679 Common Stock
May 19 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,679 Common Stock
May 17 2021	SELL Open market or private sale	$301,200 $30.12 p/Share	10,000 Reduced 4.53%	210,679 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,679 Common Stock
Apr 21 2021	SELL Open market or private sale	$322,600 $32.26 p/Share	10,000 Reduced 4.53%	210,679 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,679 Common Stock
Apr 19 2021	SELL Open market or private sale	$326,200 $32.62 p/Share	10,000 Reduced 4.53%	210,679 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.34%	220,679 Common Stock
Apr 12 2021	BUY Grant, award, or other acquisition	-	3,360 Added 1.57%	210,679 Common Stock
Apr 01 2021	SELL Open market or private sale	$146,851 $36.53 p/Share	4,020 Reduced 1.96%	200,981 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	-	10,358 Added 4.67%	211,339 Common Stock
Mar 26 2021	SELL Open market or private sale	$105,590 $35.01 p/Share	3,016 Reduced 1.48%	200,981 Common Stock
Mar 24 2021	SELL Open market or private sale	$401,800 $40.18 p/Share	10,000 Reduced 4.67%	203,997 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account